160 related articles for article (PubMed ID: 38363600)
21. Male breast cancer; analysis of 58 cases in Shiraz, South of Iran.
Tahmasebi S; Akrami M; Omidvari S; Salehi A; Talei A
Breast Dis; 2010; 31(1):29-32. PubMed ID: 20644250
[TBL] [Abstract][Full Text] [Related]
22. GATA-3 expression in male and female breast cancers: comparison of clinicopathologic parameters and prognostic relevance.
Gonzalez RS; Wang J; Kraus T; Sullivan H; Adams AL; Cohen C
Hum Pathol; 2013 Jun; 44(6):1065-70. PubMed ID: 23266442
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of ER, PR, HER-2, CK 5/6, p63 and EGFR antigen expression in medullary breast cancer.
Matkovic B; Juretic A; Separovic V; Novosel I; Separovic R; Gamulin M; Kruslin B
Tumori; 2008; 94(6):838-44. PubMed ID: 19267102
[TBL] [Abstract][Full Text] [Related]
24. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
[TBL] [Abstract][Full Text] [Related]
25. Matched-pair analysis of patients with female and male breast cancer: a comparative analysis.
Foerster R; Foerster FG; Wulff V; Schubotz B; Baaske D; Wolfgarten M; Kuhn WC; Rudlowski C
BMC Cancer; 2011 Aug; 11():335. PubMed ID: 21816051
[TBL] [Abstract][Full Text] [Related]
26. Prolactin receptor expression in gynaecomastia and male breast carcinoma.
Ferreira M; Mesquita M; Quaresma M; André S
Histopathology; 2008 Jul; 53(1):56-61. PubMed ID: 18613925
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran.
Sedighi A; Hamed EA; Mohammadian K; Behnood S; Kalaghchi B
Asian Pac J Cancer Prev; 2013; 14(12):7381-3. PubMed ID: 24460307
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic characteristics and prognosis for male breast cancer compared to female breast cancer.
Yao N; Shi W; Liu T; Siyin ST; Wang W; Duan N; Xu G; Qu J
Sci Rep; 2022 Jan; 12(1):220. PubMed ID: 34997151
[TBL] [Abstract][Full Text] [Related]
29. [Proliferation index and its prognostic value in invasive ductal breast carcinoma].
Falco M
Ann Acad Med Stetin; 2009; 55(1):22-30. PubMed ID: 20349588
[TBL] [Abstract][Full Text] [Related]
30. The prognostic significance of molecular subtype for male breast cancer: a 10-year retrospective study.
Yu XF; Feng WL; Miao LL; Chen B; Yang HJ
Breast; 2013 Oct; 22(5):824-7. PubMed ID: 23466329
[TBL] [Abstract][Full Text] [Related]
31. Aberrant expression of β-catenin in invasive ductal breast carcinomas.
Abd El-Rehim D; Ali MM
J Egypt Natl Canc Inst; 2009 Jun; 21(2):185-95. PubMed ID: 21057570
[TBL] [Abstract][Full Text] [Related]
32. [Male breast cancer: prognostic factors, diagnosis and treatment: a multi-institutional survey of 95 cases].
Oger AS; Boukerrou M; Cutuli B; Campion L; Rousseau E; Bussières E; Raro P; Classe JM
Gynecol Obstet Fertil; 2015 Apr; 43(4):290-6. PubMed ID: 25818033
[TBL] [Abstract][Full Text] [Related]
33. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
34. Poor prognosis of male triple-positive breast Cancer patients: a propensity score matched SEER analysis and molecular portraits.
Wang B; Wang H; Zhao A; Zhang M; Yang J
BMC Cancer; 2021 May; 21(1):523. PubMed ID: 33964913
[TBL] [Abstract][Full Text] [Related]
35. Lack of relationship between the expression of Hsp27 heat shock estrogen receptor-associated protein and estrogen receptor or progesterone receptor status in male breast carcinoma.
Muñoz de Toro MM; Luque EH
J Steroid Biochem Mol Biol; 1997 Mar; 60(5-6):277-84. PubMed ID: 9219918
[TBL] [Abstract][Full Text] [Related]
36. The clinical features and prognosis of patients with mucinous breast carcinoma compared with those with infiltrating ductal carcinoma: a population-based study.
Zhou X; Zheng Z; Li Y; Zhao W; Lin Y; Zhang J; Sun Q
BMC Cancer; 2021 May; 21(1):536. PubMed ID: 33975551
[TBL] [Abstract][Full Text] [Related]
37. [Analysis on the clinical and prognostic features of 71 male patients with breast cancer].
Liu DY; Xie GR; Chen M
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):187-90. PubMed ID: 23751479
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological characteristics of oestrogen receptor negative, progesterone receptor positive breast cancers: re-evaluating subsets within this group.
Ahmed SS; Thike AA; Zhang K; Lim JC; Tan PH
J Clin Pathol; 2017 Apr; 70(4):320-326. PubMed ID: 27612503
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].
Wang SL; Li YX; Song YW; Wang WH; Jin J; Liu YP; Liu XF; Yu ZH
Zhonghua Zhong Liu Za Zhi; 2010 Jul; 32(7):520-5. PubMed ID: 21029696
[TBL] [Abstract][Full Text] [Related]
40. A N0 Predicting Model for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer Upstaged From Ductal Carcinoma in Situ.
Yoo TK; Kim SJ; Lee J; Lee SB; Lee SJ; Park HY; Park HK; Chae BJ; Eom YH; Kim HS; Song BJ
Clin Breast Cancer; 2020 Jun; 20(3):e281-e289. PubMed ID: 32147404
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
